In the latest development surrounding the FDA and the tobacco category, the agency issued what it calls a Federal Register notice announcing its TPSAC review six of Reynolds’ snus products from Sept. 13-14, 2018, at the FDA’s White Oak campus in Silver Spring, Md.
The committee will discuss scientific issues related to the company’s MRTP applications for six Camel Snus smokeless tobacco products that are currently under scientific review by the FDA. These products include:
—Camel Snus Frost
—Camel Snus Frost Large
—Camel Snus Mellow
—Camel Snus Mint
—Camel Snus Robust
—Camel Snus Winterchill
On Dec. 18, 2017, the FDA filed for substantive scientific review of the six MRTP applications from Reynolds for those products.
Photo courtesy of Thinkstock